These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16854504)

  • 1. [Iatrogenic central serous chorioretinopathy during glucocorticoid therapy for temporal arteritis].
    Steichen O; Chauveheid MP; Lidove O; Doan S; Papo T
    Rev Med Interne; 2006 Sep; 27(9):702-5. PubMed ID: 16854504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Central serous chorioretinopathy and systemic steroid therapy].
    Chaine G; Haouat M; Menard-Molcard C; Favard C; Vignal-Clermont C; Campinchi-Tardy F; Massin P; Gaudric A; Badelon I; Nicolon L; Sabatier P; Guillevin L
    J Fr Ophtalmol; 2001 Feb; 24(2):139-46. PubMed ID: 11240484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual loss due to central serous chorioretinopathy during corticosteroid treatment for giant cell arteritis.
    Bevis T; Ratnakaram R; Smith MF; Bhatti MT
    Clin Exp Ophthalmol; 2005 Aug; 33(4):437-9. PubMed ID: 16033370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Corticosteroid saving-up in giant cell arteritis?].
    Schnabel A
    Dtsch Med Wochenschr; 2002 Sep; 127(37):1910. PubMed ID: 12226792
    [No Abstract]   [Full Text] [Related]  

  • 5. Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis.
    Wilson JC; Sarsour K; Collinson N; Tuckwell K; Musselman D; Klearman M; Napalkov P; Jick SS; Stone JH; Meier CR
    Semin Arthritis Rheum; 2017 Jun; 46(6):819-827. PubMed ID: 28040244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Central serous chorioretinopathy and systemic diseases report of 2 cases associated with corticotherapy].
    Bouyon A; Costedoat-Chalumeau N; Limal N; Fardeau C; Bodaghi B; Wechsler B; Piette JC
    Rev Med Interne; 2006 Jun; 27(6):487-91. PubMed ID: 16647167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment and diagnosis of polymyalgia rheumatica and temporal arteritis].
    Gran JT
    Tidsskr Nor Laegeforen; 2003 Dec; 123(23):3387. PubMed ID: 14713975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central serous chorioretinopathy in giant cell arteritis.
    Shah VA; Randhawa S; Boldt HC; Lee AG
    Semin Ophthalmol; 2006; 21(1):45-8. PubMed ID: 16517445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymyalgia rheumatica and giant cell arteritis.
    Subrahmanyan P; Dasgupta B
    Br J Hosp Med (Lond); 2006 May; 67(5):240-3. PubMed ID: 16729627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with statins does not exhibit a clinically relevant corticosteroid-sparing effect in patients with giant cell arteritis.
    García-Martínez A; Hernández-Rodríguez J; Grau JM; Cid MC
    Arthritis Rheum; 2004 Aug; 51(4):674-8. PubMed ID: 15334444
    [No Abstract]   [Full Text] [Related]  

  • 11. A 26-week feasibility study comparing the efficacy and safety of modified-release prednisone with immediate-release prednisolone in newly diagnosed cases of giant cell arteritis.
    Raine C; Stapleton PP; Merinopoulos D; Maw WW; Achilleos K; Gayford D; Mapplebeck S; Mackerness C; Schofield P; Dasgupta B
    Int J Rheum Dis; 2018 Jan; 21(1):285-291. PubMed ID: 28791802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Polymyalgia rheumatica and giant cell arteritis; diagnosis and side effects of low-dose long-term glucocorticoid therapy].
    Hatz HJ; Helmke K
    Z Rheumatol; 1992; 51(5):213-21. PubMed ID: 1476006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticosteroid-induced central serous chorioretinopathy in patients with ocular inflammatory disorders.
    Schalenbourg A; Leys A; De Courten C; Coutteel C; Herbort CP
    Klin Monbl Augenheilkd; 2002 Apr; 219(4):264-7. PubMed ID: 12022014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Temporal arteritis with giant cells].
    Bogdanici C
    Oftalmologia; 2001; 52(2):4-11. PubMed ID: 11771099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal arteritis with erythrocyte sedimentation rate <50 mm/h: a clinical reminder.
    Cheema MR; Ismaeel SM
    Clin Interv Aging; 2016; 11():185-8. PubMed ID: 26966355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central serous chorioretinopathy after renal transplantation.
    Lee CS; Kang EC; Lee KS; Byeon SH; Koh HJ; Lee SC
    Retina; 2011 Oct; 31(9):1896-903. PubMed ID: 21499191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The diagnostic risk of overlooking temporal arteritis].
    Januschowski K; Wilhelm H
    Klin Monbl Augenheilkd; 2012 Nov; 229(11):1079-82. PubMed ID: 22961039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initiation of glucocorticoid therapy: before or after temporal artery biopsy?
    Younge BR; Cook BE; Bartley GB; Hodge DO; Hunder GG
    Mayo Clin Proc; 2004 Apr; 79(4):483-91. PubMed ID: 15065613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Giant cell arteritis and scalp necrosis].
    Bygum A; Brandrup F
    Ugeskr Laeger; 2000 May; 162(18):2566-7. PubMed ID: 10846957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scalp necrosis in giant cell arteritis after initiation of therapeutic corticosteroids.
    Brick KE; Cook-Norris RH; Wetter DA; Warrington KJ
    J Am Acad Dermatol; 2010 Aug; 63(2):343-4. PubMed ID: 20633804
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.